Status epilepticus: Impact of therapeutic coma on outcome

Critical Care Medicine

Volumn 43, Issue 5, 2015, Pages 1003-1009

  Marchi, Nicola A ^a   Novy, Jan ^a   Faouzi, Mohamed ^b   Stähli, Christine ^a   Burnand, Bernard ^b   Rossetti, Andrea O ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

hospital stay; infections; mortality; prognosis; semiology; treatment

Indexed keywords

KETAMINE; MIDAZOLAM; PROPOFOL; THIOPENTAL;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN METASTASIS; CLINICAL FEATURE; COHORT ANALYSIS; COMA; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISABILITY; DISEASE ASSOCIATION; ENCEPHALITIS; EPILEPTIC STATE; FEMALE; GLIOBLASTOMA; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; LENGTH OF STAY; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MENINGOENCEPHALITIS; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; TREATMENT OUTCOME; URINARY TRACT INFECTION; AGE; CHEMICALLY INDUCED; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; SOCIOECONOMICS; STATUS EPILEPTICUS; TIME; UNCONSCIOUSNESS; UNIVERSITY HOSPITAL; VERY ELDERLY;

ACADEMIC MEDICAL CENTERS; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SOCIOECONOMIC FACTORS; STATUS EPILEPTICUS; TIME FACTORS; UNCONSCIOUSNESS;

EID: 84932149082     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000881     Document Type: Article

References (37)

1. DeLorenzo RJ, Hauser WA, Towne AR, A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996 46 1029 1035
2. Coeytaux A, Jallon P, Galobardes B, Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology 2000 55 693 697
3. Lowenstein DH, Alldredge BK, Status epilepticus. N Engl J Med 1998 338 970 976
4. Meierkord H, Boon P, Engelsen B, European Federation of Neurological Societies EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 2010 17 348 355
5. Brophy GM, Bell R, Claassen J, Neurocritical Care Society Status Epilepticus Guideline Writing Committee Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012 17 3 23
6. Novy J, Logroscino G, Rossetti AO, Refractory status epilepticus: A prospective observational study. Epilepsia 2010 51 251 256
7. Holtkamp M, Othman J, Buchheim K, Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 2005 76 534 539
8. Ferlisi M, Shorvon S, The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain 2012 135 Part 8 2314 2328
9. Rossetti AO, Lowenstein DH, Management of refractory status epilepticus in adults: Still more questions than answers. Lancet Neurol 2011 10 922 930
10. Kowalski RG, Ziai WC, Rees RN, Third-line antiepileptic therapy and outcome in status epilepticus: The impact of vasopressor use and prolonged mechanical ventilation. Crit Care Med 2012 40 2677 2684
11. Hocker SE, Britton JW, Mandrekar JN, Predictors of outcome in refractory status epilepticus. JAMA Neurol 2013 70 72 77
12. Sutter R, Marsch S, Fuhr P, Mortality and recovery from refractory status epilepticus in the intensive care unit: A 7-year observational study. Epilepsia 2013 54 502 511
13. Sutter R, Marsch S, Fuhr P, Anesthetic drugs in status epilepticus: Risk or rescue? A 6-year cohort study. Neurology 2014 82 656 664
14. Lowenstein DH, Bleck T, Macdonald RL, It's time to revise the definition of status epilepticus. Epilepsia 1999 40 120 122
15. Rossetti AO, Hurwitz S, Logroscino G, Prognosis of status epilepticus: Role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry 2006 77 611 615
16. Rossetti AO, Logroscino G, Milligan TA, Status Epilepticus Severity Score (STESS): A tool to orient early treatment strategy. J Neurol 2008 255 1561 1566
17. Sutter R, Kaplan PW, Ruegg S, Independent external validation of the status epilepticus severity score. Crit Care Med 2013 41 e475 e479
18. Charlson ME, Pompei P, Ales KL, A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987 40 373 383
19. Quan H, Sundararajan V, Halfon P, Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005 43 1130 1139
20. Towne AR, Pellock JM, Ko D, Determinants of mortality in status epilepticus. Epilepsia 1994 35 27 34
21. Logroscino G, Hesdorffer DC, Cascino G, Short-Term mortality after a first episode of status epilepticus. Epilepsia 1997 38 1344 1349
22. Koubeissi M, Alshekhlee A, In-hospital mortality of generalized convulsive status epilepticus: A large US sample. Neurology 2007 69 886 893
23. Alvarez V, Januel JM, Burnand B, Role of comorbidities in outcome prediction after status epilepticus. Epilepsia 2012 53 e89 e92
24. Rossetti AO, Alvarez V, Januel JM, Treatment deviating from guidelines does not influence status epilepticus prognosis. J Neurol 2013 260 421 428
25. Sutter R, Kaplan PW, Rüegg S, Outcome predictors for status epilepticus-What really counts. Nat Rev Neurol 2013 9 525 534
26. Drislane FW, Evidence against permanent neurologic damage from nonconvulsive status epilepticus. J Clin Neurophysiol 1999 16 323 331; discussion 353
27. Kaplan PW, No, some types of nonconvulsive status epilepticus cause little permanent neurologic sequelae (or: "the cure may be worse than the disease"). Neurophysiol Clin 2000 30 377 382
28. Meierkord H, Holtkamp M, Non-convulsive status epilepticus in adults: Clinical forms and treatment. Lancet Neurol 2007 6 329 339
29. Jordan KG, Hirsch LJ, In nonconvulsive status epilepticus (NCSE), treat to burst-suppression: Pro and con. Epilepsia 2006 47 Suppl 1 41 45
30. Holtkamp M, Masuhr F, Harms L, The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: A survey among epileptologists and critical care neurologists. J Neurol Neurosurg Psychiatry 2003 74 1095 1099
31. Ferguson M, Bianchi MT, Sutter R, Calculating the risk benefit equation for aggressive treatment of non-convulsive status epilepticus. Neurocrit Care 2013 18 216 227
32. Outin H, Blanc T, Vinatier I, le groupe d'experts [Emergency and intensive care unit management of status epilepticus in adult patients and children (new-born excluded). Société de réanimation de langue française experts recommendations]. Rev Neurol (Paris) 2009 165 297 305
33. Sutter R, Tschudin-Sutter S, Grize L, Associations between infections and clinical outcome parameters in status epilepticus: A retrospective 5-year cohort study. Epilepsia 2012 53 1489 1497
34. Spatola M, Alvarez V, Rossetti AO, Benzodiazepine overtreatment in status epilepticus is related to higher need of intubation and longer hospitalization. Epilepsia 2013 54 e99 e102
35. Knake S, Rosenow F, Vescovi M, Status Epilepticus Study Group Hessen (SESGH) Incidence of status epilepticus in adults in Germany: A prospective, population-based study. Epilepsia 2001 42 714 718
36. Jaques L, Rossetti AO, Newer antiepileptic drugs in the treatment of status epilepticus: Impact on prognosis. Epilepsy Behav 2012 24 70 73
37. Rossetti AO, Milligan TA, Vulliémoz S, A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care 2011 14 4 10